IP Library Granted Patent US 12,566,339
Granted Patent B2
US 12,566,339 · App. 17/833,290 · Granted Mar 3, 2026

Treating ocular refractive error

Inventors: Arthur Ho (Coogee, AU); Padmaja Rajagopal Sankaridurg (Maroubra, AU); Earl Leo Smith, III (Houston, TX); Brien Anthony Holden (Kensington, AU)
Assignee: Brien Holden Vision Institute Limited
G02C7/045A61F2/142G02C7/02G02C7/04G02C7/041G02C7/042G02C7/048G02C7/06G02C7/047G02C2202/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,566,339
App. No.
17/833,290
Granted
Mar 3, 2026
Kind
B2
Abstract

A lens for an eye that includes a zone with a first power profile for images received by the retina on the fovea, a zone with a second power profile for images received by the peripheral retina on the nasal side and a zone with a third power profile for images received by the peripheral retina on the temporal side. The first power profile is selected to provide clear or acceptable vision and the second and third power profiles are selected to affect the peripheral image position.

Claims (14)

1 . A lens for affecting the progression of myopia in an eye, the lens comprising:

a nasal optic zone and a temporal optic zone for refracting light to be received by the peripheral retina so as to be focused on or in front of the retina, wherein the nasal optic zone and the temporal optic zone have different refractive powers;

a central optic zone between the nasal and the temporal optic zones, the central optic zone being asymmetrical about a vertical meridian through the lens, so as to extend across horizontal half meridians of the lens to different extents, wherein the vertical and horizontal meridians refer to the orientation of the lens caused by a stabilizing mechanism.

2 . The lens of claim 1 further comprising a central optic zone with a refractive power to correct on-axis vision of the eye.

3 . The lens of claim 1 wherein the nasal optic zone has an increased power relative to a power on-axis and the temporal optic zone has a decreased power relative to the power on-axis.

4 . The lens of claim 1 wherein the temporal optic zone has an increased power relative to an on-axis power and the nasal optic zone has a decreased power relative to the on-axis power.

5 . The lens of claim 1 , wherein the central optic zone is not plano and includes a refractive power for correcting defocus.

6 . The lens of claim 1 , wherein the nasal optic zone and the temporal optic zone both include a substantially constant refractive power in a vertical direction, wherein the vertical direction is with reference to the orientation of the lens caused by the stabilizing mechanism.

7 . The lens of claim 1 , wherein the nasal and temporal optic zones have a vertical height of between 0.5 mm and 3 mm.

8 . The lens of claim 7 , further comprising a central optic zone with a refractive power to correct on-axis vision of the eye, wherein the lens has a refractive power substantially equal to the refractive power of the central optic zone above and below the nasal and temporal optic zones.

9 . The lens of claim 1 , further comprising a central optic zone with a refractive power to correct on-axis vision of the eye, wherein the central optic zone is substantially rotationally symmetrical.

10 . The lens of claim 1 , further comprising a central optic zone with a refractive power to correct on-axis vision of the eye, wherein the central optic zone is elongate in a vertical direction across the lens, wherein the vertical direction is with reference to the orientation of the lens caused by a stabilizing mechanism.

11 . The lens of claim 10 , wherein the lens is a contact lens with an optic zone and a carrier and wherein the central optic zone extends in the vertical direction across substantially the entire optic zone.

12 . The lens of claim 1 , wherein one of the nasal optic zone and temporal optic zone has a power selected to place peripheral images on the retina and the other zone has a power selected to place peripheral images off the retina.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2022
From: HO, ARTHUR; SANKARIDURG, PADMAJA RAJAGOPAL; SMITH, EARL LEO, III; HOLDEN, BRIEN ANTHONY
To: BRIEN HOLDEN VISION INSTITUTE
Reel/Frame 061074/0958 →
CHANGE OF NAME Recorded Sep 13, 2022
From: BRIEN HOLDEN VISION INSTITUTE
To: BRIEN HOLDEN VISION INSTITUTE LIMITED
Reel/Frame 061074/0995 →
Priority Claims (1)
AU 2010903334 · Jul 26, 2010 · national
Continuity (4)
Continuation 16595019 · Oct 7, 2019
Continuation 15209295 · Jul 13, 2016
Division 13812480
Related Publication 20220404640A1 · Dec 22, 2022
References Cited (42)
US 5151723A · Tajiri · 1992 [cited by applicant]
US 5800532A · Lieberman · 1998 [cited by applicant]
US 6045578A · Collins et al. · 2000 [cited by applicant]
US 6234629B1 · Neadle et al. · 2001 [cited by applicant]
US 6343861B1 · Kris et al. · 2002 [cited by applicant]
US 6752499B2 · Aller · 2004 [cited by applicant]
US 6899425B2 · Roffman · 2005 [cited by examiner]
US 7025460B2 · Smith et al. · 2006 [cited by applicant]
US 7665842B2 · Ho · 2010 [cited by applicant]
US 9248614B2 · Phelan · 2016 [cited by examiner]
US 20030220631A1 · Clapham · 2003 [cited by examiner]
US 20060001184A1 · Phelan et al. · 2006 [cited by applicant]
US 20070159601A1 · Ho · 2007 [cited by applicant]
US 20080062380A1 · Phillips · 2008 [cited by examiner]
US 20090122264A1 · Ho · 2009 [cited by examiner]
US 20100036489A1 · Lindacher et al. · 2010 [cited by applicant]
US 20100097570A1 · Katzman et al. · 2010 [cited by applicant]
US 20100195044A1 · Collins et al. · 2010 [cited by applicant]
US 20100296058A1 · Ho et al. · 2010 [cited by applicant]
US 20110037944A1 · Varnas · 2011 [cited by applicant]
US 20120140165A1 · Soriano et al. · 2012 [cited by applicant]
US 20150250583A1 · Rosen · 2015 [cited by applicant]
US 20170146824A1 · Martinez · 2017 [cited by applicant]
CN 101686801 · 2010 [cited by applicant]
JP 2009524085 · 2009 [cited by applicant]
NZ 515069 · 2003 [cited by applicant]
RU 2186417C2 · 2002 [cited by applicant]
WO WO2000059402 · 2000 [cited by applicant]
WO WO2003009053 · 2003 [cited by applicant]
WO WO2006004440 · 2006 [cited by applicant]
WO WO2007082268 · 2007 [cited by applicant]
WO WO2008116270 · 2008 [cited by applicant]
WO WO2009034602 · 2009 [cited by applicant]
WO WO2009055638 · 2009 [cited by applicant]
WO WO2009129528 · 2009 [cited by applicant]
WO WO2010103160 · 2010 [cited by applicant]
European Search Report dated Dec. 15, 2016 for EP 11811639. [cited by applicant]
English Translation of Search Report of Taiwan Patent Application No. 100126384 dated Aug. 20, 2015. [cited by applicant]
Vision CRC Limited, First Office Action, CN 201180045576.4, Sep. 28, 2014, 22 pgs. [cited by applicant]
Vision CRC Limited, International Search Report and Written Opinion, PCT/AU2011/000940, Aug. 24, 2001, 19 pages. [cited by applicant]
Lundstrom, L et al., “Peripheral Optial Erros and Their Change with Accommodation Differ Between Emmetropic and Myopic Eyes, Article 17” Journal of VI, Association for Research in Vision and Ophthalmology, US, vol. 9, N… [cited by applicant]
Ho, A et al., “Change in Peripheral Refraction and Curvature of Field of theHuman Eye with Accommodation”, vol. 7163, Feb. 18, 2009, pp. 1-6. [cited by applicant]